Drug Shortage Report for KENALOG-40 INJECTION 40MG/ML

Last updated on 2023-01-31 History
Report ID 160669
Drug Identification Number 01999869
Brand name KENALOG-40 INJECTION 40MG/ML
Common or Proper name Triamcinolone Acetonide
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR
Packaging size 1ml
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-05-16
Actual start date 2022-05-16
Estimated end date 2023-01-27
Actual end date 2023-01-30
Shortage status Resolved
Updated date 2023-01-31
Company comments Demand increase for the drug.
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-05-16 English Compare
v2 2022-05-16 French Compare
v3 2022-05-17 English Compare
v4 2022-06-03 English Compare
v5 2022-06-03 French Compare
v6 2023-01-27 English Compare
v7 2023-01-27 English Compare
v8 2023-01-27 French Compare
v9 2023-01-27 English Compare
v10 2023-01-27 French Compare
v11 2023-01-31 English Compare

Showing 1 to 11 of 11